The University of Chicago Header Logo

Connection

Hans Schreiber to Immune Tolerance

This is a "connection" page, showing publications Hans Schreiber has written about Immune Tolerance.
Connection Strength

0.343
  1. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy. J Exp Med. 1997 Jul 21; 186(2):229-38.
    View in: PubMed
    Score: 0.123
  2. Cancer. Awakening immunity. Science. 2010 Nov 05; 330(6005):761-2.
    View in: PubMed
    Score: 0.077
  3. Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med. 2005 Mar 07; 201(5):779-91.
    View in: PubMed
    Score: 0.052
  4. Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide. J Immunol. 2001 Jun 15; 166(12):7151-7.
    View in: PubMed
    Score: 0.040
  5. Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro. Tissue Antigens. 1996 May; 47(5):399-407.
    View in: PubMed
    Score: 0.028
  6. A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target. J Exp Med. 1993 Sep 01; 178(3):933-40.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.